| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Drug Dev Solutions | President, Integrated Drug Dev
1 company
Smith Patrick F is a President, Drug Dev Solutions at CERT. Recent filings cover 0 purchases and 13 sales. Those positions are worth an estimated $553K at current prices.
Our model assigns Smith Patrick F a middling insider score of 65/100, based on 8 past trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +10.3%.
Smith Patrick F's largest disclosed position is in CERT as President, Drug Dev Solutions, worth about $553K. The recent filings there lean toward selling, a net 69,679 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2024 | CERT Certara, Inc. | President, Drug Dev Solutions | Sell | 5,409 | $11.03 | $59,661.27 | -9.7% | +2.1% | +16.5% | |
| Apr 2, 2024 | CERT Certara, Inc. | President, Drug Dev Solutions | Sell | 14,427 | $16.85 | $243,161.42 | -22.4% | -19.5% | -39.6% | |
| Feb 20, 2024 | CERT Certara, Inc. | President, Drug Dev Solutions | Sell | 5,000 | $18.00 | $90,000.00 | -8.3% | -5.6% | -19.0% | |
| Jun 5, 2023 | CERT Certara, Inc. | President, Integrated Drug Dev | Sell | 19,104 | $21.55 | $411,691.20 | -24.2% | -29.7% | -20.9% | |
| Nov 9, 2022 | CERT Certara, Inc. | President, Integrated Drug Dev | Sell | 2,387 | $13.48 | $32,176.76 | -3.1% | +37.0% | -9.1% | |
| Aug 16, 2022 | CERT Certara, Inc. | President, Integrated Drug Dev | Sell | 10,000 | $17.71 | $177,100.00 | -11.3% | -15.5% | -4.2% | |
| Jun 8, 2022 | CERT Certara, Inc. | President, Integrated Drug Dev | Sell | 10,000 | $19.16 | $191,600.00 | -10.2% | -19.2% | -9.7% | |
| Apr 4, 2022 | CERT Certara, Inc. | President, Integrated Drug Dev | Sell | 3,352 | $22.29 | $74,716.08 | -3.3% | +1.3% | +3.9% |